Visfatin/Pre-B-cell Colony-enhancing Factor (PBEF), a Proinflammatory and Cell Motility-changing Factor in Rheumatoid Arthritis
Florian Meier(Goethe University Frankfurt), Elena Neumann(Kerckhoff Klinik)
Cited by 63
Related Papers
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
|Arthritis Research & Therapy|2011|212